MannKind

Mannkind executive chairman Alfred Mann steps down

Friday, February 19, 2016

Alfred E. Mann has resigned as executive chairman and as a board member of MannKind, effective immediately. MannKind named Kent Kresa as chairman of the board and also named Mann as chairman emeritus of MannKind. Mann will continue to advise the company as an employee in a non-executive capacity. 

[Read More]

FDA approves Afrezza to treat diabetes

Monday, June 30, 2014

The FDA has approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control in adults with diabetes mellitus. Afrezza is a rapid-acting inhaled insulin that is administered at the beginning of each meal.

[Read More]